Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease

Clinical Infectious Diseases

Volumn 43, Issue 10, 2006, Pages 1239-1245

  Klement, Eyal ^a   Talkington, Deborah F ^e   Wasserzug, Oshri ^a   Kayouf, Raid ^a   Davidovitch, Nadav ^a,b,h   Dumke, Roger ^f   Bar Zeev, Yael ^a   Ron, Merav ^c   Boxman, Jonathan ^a   Thacker, W Lanier ^e   Wolf, Dana ^c   Lazarovich, Tsilia ^d   Shemer Avni, Yonat ^b   Glikman, Daniel ^c,i   Jacobs, Enno ^f   Grotto, Itamar ^a,b   Block, Colin ^c   Nir Paz, Ran ^c,g  

^a Army Health Branch   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UC Berkeley ^*  (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL EXAMINATION; COHORT ANALYSIS; EPIDEMIC; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INFECTION RISK; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; OCCUPATIONAL HAZARD; OCCUPATIONAL LUNG DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SERODIAGNOSIS; SMOKING; SMOKING CESSATION; SOLDIER; SYMPTOM;

COHORT STUDIES; COMMUNICABLE DISEASES; COMMUNITY-ACQUIRED INFECTIONS; DISEASE OUTBREAKS; HUMANS; MILITARY PERSONNEL; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 33750687332     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508458     Document Type: Article

References (34)

1. Layani-Milon MP, Gras I, Valette M, et al. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods. J Clin Microbiol 1999; 37:1721-6.
2. Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, Principi N. Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis. Eur J Clin Microbiol Infect Dis 2002; 21:607-10.
3. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17:697-728.
4. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17(Suppl 1):S37-46.
5. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157:1709-18.
6. Porath A, Schlaeffer F, Lieberman D. The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect 1997; 34:41-8.
7. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003; 36:267-78.
8. Feikin DR, Moroney JF, Talkington DF, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy, new implications from an old scenario. Clin Infect Dis 1999; 29:1545-50.
9. Kleemola M, Jokinen C. Outbreak of Mycoplasma pneumoniae infection among hospital personnel studied by a nucleic acid hybridization test. J Hosp Infect 1992; 21:213-21.
10. Klausner JD, Passaro D, Rosenberg J, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis. J Infect Dis 1998; 177:161-6.
11. Leibowitz Z, Schvartzman P, Epstein L, Lis I, Naot Y. An outbreak of Mycoplasma pneumoniae pneumonia in two kibbutzim: a clinical and epidemiologic study. Isr J Med Sci 1988; 24:88-92.
12. Foy HM, Kenny GE, McMahan R, Kaiser G, Grayston JT. Mycoplasma pneumoniae in the community. Am J Epidemiol 1971; 93:55-67.
13. Orr N, Klement E, Gillis D, et al. Long-term immunity in young adults after a single dose of inactivated hepatitis A vaccines. Vaccine 2006; 24:4328-32.
14. Waites KB, Bebear CM, Robertson JA, Talkington DF, Kenny GE. Laboratory diagnosis of mycoplasmal infections. Washington, DC: American Society for Microbiology, 2001.
15. Abele-Horn M, Busch U, Nitschko H, et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol 1998; 36:548-51.
16. Shuvy M, Rav-Acha M, Izhar U, Ron M, Nir-Paz R. Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report. BMC Infect Dis 2006; 6:18.
17. Liu G, Talkington DF, Fields BS, Levine OS, Yang Y, Tondella ML. Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia. Diagn Microbiol Infect Dis 2005; 52:7-14.
18. Dumke R, Lück PC, Schäfer C, et al. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 2006; 44:2567-70.
19. Black CM, Fields Pl, Messmer TO, Berdal BP. Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers. Eur J Clin Microbiol Infect Dis 1994; 13:752-6.
20. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70:228-39.
21. Poddar SK. Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis. J Virol Methods 2002; 99:63-70.
22. van den Hoogen BG, van Doornum GJ, Fockens JC, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003; 188:1571-7.
23. Sande MA, Gadot F, Wenzel RP. Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory. Am Rev Respir Dis 1975; 112:213-7.
24. Andrews CE, Hopewell P, Burrell RE, Olson NO, Chick EW. An epidemic of respiratory infection due to Mycoplasma pneumoniae in a civilian population. Am Rev Respir Dis 1967; 95:972-9.
25. Dorigo-Zetsma JW, Zaat SA, Vriesema AJ, Dankert J. Demonstration by a nested PCR for Mycoplasma pneumoniae that M. pneumoniae load in the throat is higher in patients hospitalised for M. pneumoniae infection than in non-hospitalised subjects. J Med Microbiol 1999; 48:1115-22.
26. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds Al, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001; 183:675-8.
27. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994; 49:825-34.
28. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164:2206-16.
29. Nir-Paz R, Michael-Gayego A, Ron M, Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect 2006; 12:685-8.
30. McCormick DP, Wenzel RP, Senterfit LB, Beam WE Jr. Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults. Infect Immun 1974; 9:53-9.
31. Mogabgab WJ. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel, 1964-1966. Am Rev Respir Dis 1968; 97:359-65.
32. Mogabgab WJ. Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population. Am Rev Respir Dis 1973; 108:899-908.
33. Wenzel RR Craven RB, Davies JA, Hendley JO, Hamory BH, Gwaltney JM Jr. Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis 1977; 136(Suppl):S204-7.
34. Chisick MC, Poindexter FR, York AK. Comparing tobacco use among incoming recruits and military personnel on active duty in the United States. Tob Control 1998; 7:236-40.